E Keller

Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy

Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins −1, −2, −3 and GH binding protein during progression of liver cirrhosis

Favorable Final Height Outcome in Girls with Ullrich-Turner Syndrome Treated with Low-Dose Growth Hormone Together with Oxandrolone Despite Starting Treatment After 10 Years of Age